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Abstract
The superantigen SEA causes non-specific hyperactivation of T and B cells at low concentrations. Studies of mutants or
soluble proteins suggest SEA is bivalent for its ligand, MHC class II. However, the interaction between these molecules on
intact cells is unknown. On primary mouse B cells expressing the MHC class II allele HLA-DR1, measurements of Fo ¨rster
Resonance Energy Transfer between HLA-DR1 molecules on SEA-treated cells indicated specific clustering, not observed in
untreated or monovalent superantigen treated cells. Tomographic visualization and electron microscopy of immunogold-
labeled SEA-treated B cells revealed small clusters of surface HLA-DR1 (#4 gold labels). These results present direct visual
evidence of SEA-mediated clustering of MHC class II molecules on treated antigen presenting cells, and provide a new
structural approach to addressing problems of this nature.
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Introduction
The term ‘‘Superantigen’’ is used to define endogenous or
exogenous factors that can stimulate T cells whose T Cell
Receptors (TCR) bear specific Vb domains, irrespective of the
composition of the rest of the receptor [1], resulting in the
stimulation of a large fraction (up to 20%) of the T cell population
[2]. Some of the most potent exogenous superantigens (SAgs)
known to man are the enterotoxins secreted by Staphylococcal
bacteria. Staphylococcal Enterotoxins (SEs) are a family of
structurally related basic secretory proteins that are important
virulence factors for the pathogen. By mediating massive cellular
proliferation and cytokine secretion at extremely low concentra-
tions (5,6), these SAgs can cause systemic pathology in the host,
ranging from nausea and fever up to toxic shock and death [3,4].
SEs can bind relatively non-polymorphic regions outside the
peptide binding groove of MHC class II molecules on Antigen
Presenting Cells (APCs) [5,6,7] as well as conserved Vb regions of
TCR molecules [8,9,10], leading various groups to hypothesize
that these SAgs may act as a binding ‘‘bridge’’ between MHC class
II and TCR, resulting in downstream signaling events and
immune activation [11,12,13].
One of the most potent SEs is Staphylococcal Enterotoxin A
(SEA), with an exceedingly low half-maximum stimulating dose of
0.1 pg/mL [2]. SEA is somewhat atypical in that it has two
binding sites for two corresponding sites on MHC class II, a high
affinity Zinc coordinating site on the b chain of MHC class II [14]
and a second weaker (.1 mM affinity) binding site on the a chain
that has been shown to play an important role in the complete
functional activity of SEA [15,16]. Studies have suggested a
cooperative model where the binding of one SEA to MHC class II
favors the binding of the second SEA molecule [13,17,18], and
MHC class II - (SEA)2 trimers have been isolated in solution [18].
These results have led to the speculation that SEA could crosslink
multiple MHC class II molecules on the surface of APCs. Indeed,
when MHC class II expressing cell lines were treated with SEA,
but not with mutants missing either binding site or toxins with one
MHC class II binding site, downstream signaling [19,20],
inflammatory cytokine gene upregulation [19] and homotypic
aggregation [21] was observed, even in the absence of T cells.
These results hint a role for a multivalent binding mode between
SEA and MHC class II, and indeed, many subsequent studies on
superantigens have assumed this multivalency of SEA as part of its
functionality. However, the actual membrane reorganization of
MHC class II on the surface of a cell in response to SEA treatment
has not been directly probed, and as such, remains unknown.
In this study, using advanced optical spectroscopic and electron
microscopic techniques we demonstrate that the binding of SEA
via both of its binding sites to MHC class II on the surface of
primary B cells induces small clusters of these molecules. Working
with transgenic mice developed in our lab that express only the
MHC class II allele HLA-DR1 (DR1), we measure Fo ¨rster
Resonance Energy Transfer (FRET) between antibody-labeled
DR1 molecules. We show that the addition of SEA results in the
increased clustering of DR1 in a dose dependent manner, and is
dependent on both binding sites. We employ electron tomography,
which allows us to directly visualize the three-dimensional
distribution of immuno-gold-labeled DR1 molecules on the
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labeling followed by 2D transmission electron microscopy. We
observe a significant increase in small-scale clustering of MHC
class II on SEA treatment over controls. These results provide
evidence that SEA likely mediates the formation of small MHC
class II clusters or ‘‘daisy-chain oligomers’’ on the B cell surface,
and does not aggregate or coalesce large numbers of MHC class
II.
Methods
SDS-PAGE
SDS-PAGE experiments were performed essentially as previ-
ously described [22]. 1 mM wtDR1 was incubated in the absence
or presence of 50 mM of the immunodominant peptide derived
from Influenza Hemagglutinin HA306-318 (PKYVKQNTLKLAT)
or its synthetic variant HAY308A (PKAVKQNTLKLAT) at 37uC
for 48 h in PBS+10 mM ZnCl2 pH 7.4. The wtDR1/HAY308A
complexes were incubated for an additional hour with a molar
equivalent of soluble SEA or SEH before mixing with equal
volumes of SDS-PAGE sample buffer containing 0.2% SDS and
incubating for 10 min at room temperature. These samples were
then applied to 12% PAGE gels, and the gels were silver stained
according to standard protocols.
Surface Plasmon Resonance measurements
Cys-HA306–318 peptides were immobilized on an SMPB
activated CM5 chip in a BIAcore 2000 instrument and wtDR1/
HAY308A complexes (,2.5 mM) were allowed to bind to the
peptide surface for ten minutes [23]. Complexes were allowed to
dissociate for approximately three minutes, after which a solution
of wtDR1/HAY308A complexes (,2.5 mM) pre-incubated with
SEH or SEA at a 1:1 molar stoichiometry was injected over the
surface of flow cell 1 or 2 respectively for another ten minutes. To
control for DR1 binding to freshly dissociated peptides on the
chip, a second injection of wtDR1/HAY308A alone was performed
on a control flow cell. In all cases a quick spin in a G-50 column
equilibrated with PBS+10 mM ZnCl2 was performed to remove
excess peptide and to exchange buffer. RUs were measured ,3
seconds after end of injections to exclude the common artifact of
sudden RU changes caused by small changes in pH or protein or
ion concentrations. The linear association curves were caused by
mass-transport binding as a result of low analyte concentration in
the injection solution. The running buffer was PBS+10 mM ZnCl2,
pH 7.4, and flow speed was maintained at 5 mL/min.
Labeling of Antibodies
The anti-HLA-DR probe used in all experiments was the mouse
IgG1 monoclonal antibody L243. The antibodies were labeled
with Cy3 or Cy5 fluorophores (Amersham Biosciences, UK)
according to the manufacturers’ protocols. The labeled antibodies
were separated from excess dye using a size-separation column
and stored at 4uC. The Dye-to-protein (D/P) ratios were
approximately 2.5:1 for all experiments. There were no noticeable
aggregates in the size exclusion profile, and the labeled antibodies
were used for experiments within three months of preparation.
Affinity measurements of antibodies
Single cell suspensions of fresh DR1 transgenic mouse
splenocytes (see below) were incubated with 2.5 mg soluble SEA,
SEH (Toxin Technologies, CA) or no enterotoxin per 1610
6 cells
for 30 minutes, washed and stained with doubling dilutions of Cy3
conjugated L243. After washing, the cells were then analyzed by
flow cytometry on a FACSCalibur (BD Biosciences). The Mean
Fluorescence Index (MFI) of gated cells was then plotted against
Antibody concentration, and the data fit to a simple saturating
binding curve, as described by the equation
Y~Bmax: X ½  = Kdz X ½  ðÞ
where Y was the MFI value measured by flow cytometry, Bmax is
the maximal binding at equilibrium, X is the antibody concentra-
tion, and Kd is the equilibrium dissociation constant.
Mice and cells
In all experiments, male wtDR1 transgenic mice (C57BL/6
background) of age 8–10 weeks were used as the source of cells.
These mice are normal and express the human class II allele HLA-
DR1 as their only MHC class II molecule at normal levels of
expression (Dalai SK and Sadegh-Nasseri, unpublished data).
Single cell suspensions were generated from naı ¨ve spleens, and B
cells (.90% purity, Supplementary Fig. S2) were generated by
negative selection using CD43 magnetic beads (MACS, Miltenyi
Biotec) according to the manufacturers protocols. After washing
and resuspending in media, the cells (usually 1610
6 purified B cells
per group) were incubated with various concentrations of the
specified enterotoxin in media for 45 minutes at 37uC, washed in
FACS buffer (PBS pH 7.4+1% FCS+0.005% NaN3), and then
prepared for FRET or EM measurements, as detailed below. All
mice were housed in a Johns Hopkins University animal facility
under virus-free conditions. All experiments involving mice were
performed with protocols approved by the Animal Care and Use
Center of the Johns Hopkins School of Medicine.
Confocal Microscopy and FRET measurements
Preparation of cells. The following steps were performed at
4uC and in FACS buffer unless otherwise specified. Freshly
isolated B cells that were previously incubated either with or
without enterotoxin at 37uC were incubated with anti-Fc
antibodies for 20 minutes, washed, and incubated for 1 hour
with saturating concentrations of fluorophore conjugated L243.
Ratios of 1:1, 1:2, or 1:4 Donor (Cy3): Acceptor (Cy5) were used.
Care was taken to keep total antibody concentrations constant and
well above saturation (,2 mM). The cells were then washed and
resuspended in PBS, then fixed in 4% fresh paraformaldehyde at
room temperature for 30 minutes. To test for capping by confocal
microscopy or electron microscopy, negatively selected B cells
were incubated with saturating concentrations of either
unconjugated L243 or L243-FITC, washed, and incubated with
Gold-labeled or unlabeled goat anti-mouse IgG polyclonal
antibodies at 37uC, respectively. To test for internalization, B
cells were incubated with SEA for various lengths of time at 37uC
and stained with L243-FITC at 4uC.
Microscopy. All the experiments for this section were
performed on a Zeiss LSM 510 Meta confocal microscope at
the Integrated Imaging Center, Johns Hopkins University, and the
data analyzed on Zeiss Analysis software. The fixed B cells were
allowed to rest on cover slips and then imaged at 636
magnification using a Zeiss Apochromat objective with
averaging factor of 4 to increase the Signal-to-noise ratio.
Emission from Cy3 and Cy5 were detected using appropriate
filter sets (Cy3: excitation 543 nm and emission Band Pass 560–
615 nm. Cy5: excitation 633 nm and emission Band Pass 646–
753 nm of the META spectral detector). A multi-time bleach
macro was utilized to run the following loop: (i) pre-bleach - images
of several Cy3 and Cy5 labeled B cells were recorded in their
respective channels; (ii) photobleach - the acceptor Cy5 on these cells
MHC Small Clusters on B Cell
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interest (ROI). The photobleach program was set up to achieve
.85% bleaching of the acceptor (the donor was not bleached); (iii)
post-bleach - the same cells were imaged again using the same
parameters as the pre-bleach, and the fluorescent intensities in all
cases quantified.
Several iterations of the loop were executed to image as many
cells as possible at various (x,y) coordinates on the cover slip. In
most experiments at least 50 cells for each Donor: Acceptor (D:A)
ratio per group were imaged and analyzed. The quantified
intensities of various ROIs in the donor and acceptor channels
were then used for the calculation of FRET efficiencies using
software provided by Zeiss. Cells that were only Donor labeled,
irrespective of experimental group, showed no FRET as measured
by Acceptor Photobleach experiments (data not shown).
Immunolabeling and Transmission Electron Microscopy
Preparation of cells. Fresh B cells were prepared and
incubated with enterotoxin as above; here, after blocking with
anti-Fc antibodies the cells were incubated with saturating
concentrations (,5 mM) of unlabelled L243 for 1 hour at 4uC.
In the case of the EM experiments, either 5 or 10610
6 purified B
cells were used per group. After washing, the cells were fixed in
4% paraformaldehyde, washed twice in PBS+2.5% FCS and
incubated overnight at 4uC in saturating concentrations of donkey
anti-mouse antibodies conjugated to 6 nm Gold Beads (Jackson
ImmunoResearch Labs, PA) and washed again.
Microscopy. The cells were fixed in 3%
Paraformaldehyde+1.5% Glutaraldehyde, post-fixed in OsO4,
pelleted, embedded and prepared as previously described [24].
The block containing the cell pellet was cut to fit in a Leica UCT
ultramicrotome and thin sections (80 nm) were collected on
uncoated grids, and post-stained with lead citrate and uranyl
acetate. Projection electron microscopic images were recorded at
magnifications in the range between 450006and 540006using a
Philips EM 410 or 420 transmission electron microscope equipped
with a SIS Megaview III CCD digital camera and analyzed using
the AnalySIS software (Olympus).
Distance Measurements. Using ‘‘blind’’ samples, at least 30
slices per group were examined. The distances between adjacent
gold beads were then measured along the contour of the cell
membrane (this is not possible for the 3D images, as the gold beads
are rendered as points in space). It is important to note that this
measure of clustering is unable to quantitatively determine the
number of MHC class II molecules clustered primarily because
technical limitations with antibody staining preclude a labeling
efficiency of 100%. Also, the 2-D measurements do not account
for the width of the sections. However, care was taken to keep the
sections thin (80 nm) and of the same thickness across the groups.
In addition, all groups were treated and measured in exactly the
same way, and the experiments were conducted blind. Hence, this
is a valid method to compare relative differences in cell surface
distribution of DR1 between those groups, within an experiment.
Electron Tomography
250 nm thick sections were prepared in the same way as
described above for the thin sections. 15 nm gold fiducial beads
were deposited on the grids to aid alignment of tilt series.
Collection of tilt series and reconstruction of tomograms was
performed as previously described [25]. Briefly, a series of
projections of the region of interest were taken at various tilt
angles (260u to +60u,2 u increments) and recorded using a 2k62k
CCD (Supplementary Movie S1). The resulting images were
back-projected and aligned using the IMOD package (IMOD,
etomo [26,27]) to generate the tomogram (Supplementary
Movie S2). The tomograms were segmented using Amira (Amira
3.1, Mercury Computer Systems GmbH, Berlin, Germany); the
cell membrane and the electron dense gold beads are highlighted
in purple and as golden spheres, respectively, to generate the final
images and/or movies (Supplementary Movie S3).
Results
SEA and SEH bind DR1 and confer SDS stability to
peptide-DR1 complexes
In order to test the binding and potential crosslinking of
recombinant DR1 molecules by SEA in solution, we performed a
‘‘gentle SDS’’ PAGE assay to probe the conformational stability of
DR1 complexes [22,28]. Soluble peptide-DR1 complexes that
were SDS-unstable were pre-incubated with SEA or the control
Staphylococcal Enterotoxin H (SEH), then incubated with SDS
for an additional 2 minutes without boiling, and the solution was
run on a gel in the presence of SDS under non-reducing
conditions (Fig. 1A). SEH is a well-characterized superantigen
[2,29] with a similar overall fold and Zinc dependent binding site
as SEA; however, SEH does not possess a second binding site, and
is therefore a good ‘‘non-clustering’’ control. The SDS-unstable
complexes (lane 3) now attained SDS stability and migrated
differently (lanes 4 and 6), suggesting that SEA and SEH bound
and conferred rigid SDS stable conformations to otherwise
unstable peptide-DR1 complexes. However, there was an absence
of supershifted bands (Fig. 1A, *) suggesting that no detectable
aggregates were formed. In addition, in a size-exclusion experi-
ment where equal amounts of soluble SEA or SEH and soluble
DR1 were incubated in the presence of excess ZnCl2 or EDTA (to
disrupt the Zn
2+ binding site) and run on a pre-equilibrated size-
exclusion column, no high molecular weight peaks corresponding
to SEA-DR1 multimers were observed (data not shown).
Real time binding experiments reveal SEA but not SEH
crosslinks DR1
The gel-based experiments could not conclusively demonstrate
the crosslinking of soluble recombinant DR1 molecules by SEA.
Hence, we attempted to follow the binding of these two molecules
in real-time using Surface Plasmon Resonance. In a BIAcore
experiment, a solution of DR1 was allowed to bind to HA306–318
peptides immobilized on a CM5 chip. After flowing buffer for a
short period, a second injection of DR1 pre-incubated with either
SEH or SEA at a 1:1 molar stoichiometry was performed. Given
that one of the two binding sites on SEA is a weak binding site of
micromolar affinity [1,21], we hypothesized that there may exist a
fraction of SEA in solution that remained bound to DR1 through
only one binding site. This would allow SEA-DR1 complexes to
bind transiently to the DR1 on the chip via the second binding site
on SEA, whereas SEH-DR1 should show little or no such binding.
Fig. 1B shows the real time raw binding data measured in
Response units (RUs) from one of two experiments. There was
stable binding of DR1 to the peptide-immobilized surfaces in both
flow channels (*). However, in the second binding step (**), SEH-
DR1 (blue) showed only a small amount of binding. The RU
change was similar to a control flow cell treated with two
consecutive DR1 injections (Fig. 1B, inset), suggesting that in the
SEH-DR1 and control DR1 only group, some binding was seen
between free DR1 from the second injection and peptide freshly
dissociated from DR1 from the first injection. However, the
addition of a molar equivalent of SEA-DR1 (red) to immobilized
DR1 resulted in an increase of 55 RUs, which was greater than the
RU change observed with SEH-DR1 or DR1 alone (,40 RUs).
MHC Small Clusters on B Cell
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the SEH curve, and there was 30% more ligand bound as
compared to controls at the end of the injection. The sudden
changes in RU at the start of the injection and linear association
curves are common SPR artifacts (see Materials and Methods).
Thus, at least for a fraction of the molecules present in solution,
SEA but not SEH can crosslink two molecules of DR1, forming
DR1-SEA-DR1 trimers.
SEA induces clustering of DR1 on the surface of B cells as
measured by FRET
We next attempted to visualize the interaction between SEA
and DR1 on the surface of cells. Here, we used Fo ¨rster Resonance
Energy Transfer (FRET) as a tool to visualize the clustering of
DR1 on the surface of B cells. The primary advantage of FRET is
the ability to dissect molecular interactions that are spatially
separated by distances that are much smaller than the resolution
offered by light microscopy [30,31], ,50 A ˚ for the fluorophore
pair used here. The methods and mathematical modeling of the
translation of efficiency of FRET into extent of clustering have
already been elucidated [30] and are explained briefly in Materials
and Methods. In order to monitor SEA-DR1 interactions on cell
membranes, we utilized a transgenic mouse that expressed the
human MHC class II molecule HLA-DR1 as the only MHC class
II molecule on the surface of its antigen presenting cells (DR1 tg
mice, [32] and Dalai, S and S. Sadegh-Nasseri, unpublished data).
Single cell suspensions of B cells negatively isolated from DR1 tg
mice spleens were incubated with or without SAg in the presence
or absence of excess EDTA for ,45 minutes at 37uC. The time of
incubation was presumably long enough to allow for membrane
clustering events to take place, since in the capping experiments
(see below), significant membrane DR1 aggregation had already
taken place within 15 minutes (Supplementary Fig. S1). The
incubation was short enough that internalization of SAg or DR1
itself was minimal [21,33,34,35]. Even at low resolution, it was
clear that the addition of SEA did not cause internalization of
DR1 on B cells, in agreement with published data from other
groups [33], nor did it mediate aggregation of these molecules,
whereas the addition of anti-DR1 and polyclonal secondary
antibodies at 37uC caused capping of these surface proteins
(Supplementary Fig. S1).
For the cells in each of the groups, FRET assays were
performed to gauge the presence of membrane clustering of
DR1. Here, DR1 molecules on the B cells were labeled with
‘‘donor’’ fluorophore Cy3-conjugated and ‘‘acceptor’’ fluorophore
Cy5-conjugated monoclonal antibodies at various Donor:Acceptor
(D:A) antibody ratios. We used the exact same monoclonal
antibody, L243, against DR1 as donor and acceptor, and added
the reagent at well above saturating concentrations to ensure that
the FRET measurements would accurately reflect the extent of
clustering of that receptor. This is an important point; the
bivalency of the whole antibody is rendered irrelevant at saturating
doses, so L243 mediated crosslinking of DR1 molecules (which
would have been a maximum of two molecules at any rate) is
minimal. Also, because we use the same antibody (separately
labeled by donor or acceptor fluorophores) against DR1, we
neither induce large-scale antibody mediated aggregation of DR1
nor generate false FRET signals, since each DR1 molecule can be
bound only by one antibody molecule. An antibody binding
experiment showed that there was no significant change in the
affinity (Kd) and only a small change in maximal binding (Bmax)
of labeled L243 to HLA-DR1 in the presence or absence of
enterotoxin (Table 1). The addition of SEA over time caused a
very modest reduction in the labeling of DR1 by the antibodies
(Supplementary Fig. S2), suggesting that any changes in
receptor density or receptor labeling upon this treatment were
minimal. Shown in Fig. 2 is one cell (in this case, expected to show
clustering) out of at least 50 cells that were imaged for each
experimental group, in one out of at least two experimental runs.
The surface labeling of DR1 was slightly variable across various
areas of each cell, but there was no evidence of receptor capping
(Fig. 2A). In cells imaged before and after photobleaching the
Figure 1. SEA and SEH bind HLA-DR1 in solution. (A) SEA-DR1 and SEH-DR1 complexes are SDS stable. Various Enterotoxins in the presence or
absence of HLA-DR1/peptide complexes were incubated in PBS with a final SDS concentration of 0.1%, for 5 min at room temperature and subjected
to electrophoresis in a 12% polyacrylamide gradient gel. The gel was silver stained by standard protocols. There was no evidence of multimer
formation (*) Lane 1: empty DR1. Lane 2: DR1/HA306-318 complex. Lane 3: DR1/HAY308A complex. Lane 4: SEA+DR1/HAY308A Lane 5: SEA only Lane 6:
SEA+DR1/HAY308A Lane 7: SEH only. (B) SEA-DR1 but not SEH-DR1 complexes can bind an additional DR1. A solution of DR1 was injected on a HA306-318
peptide decorated BIAcore CM5 chip (*) and allowed to dissociate for 3 minutes. A second injection (**) of preformed SEA-DR1 (red) resulted in a 30%
greater RU change than SEH-DR1 (blue), as measured by the difference between the solid and dashed arrows. Two consecutive injections of DR1
alone on a control flow cell (inset) showed the same fold increase in RUs as SEH-DR1. m, start of injection.
doi:10.1371/journal.pone.0006188.g001
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photobleached areas showed significant increases in donor
intensities, indicative of high DR1 clustering (Fig. 2B, iii, iv),
while unbleached sections showed no change, as expected (v, vi).
The changes in Donor and Acceptor Intensities upon photo-
bleaching were used to compute the FRET efficiency for each
region or cell imaged (ii). Plotting the FRET efficiency against the
brightness of the acceptor before photobleaching, i.e. the density
of acceptor labeled antibody bound to HLA-DR1, for all cells
allows for the estimation of the extent of clustering of the HLA-
DR1 for each group. Based on the theory detailed in Materials
and Methods and [30], an increase in the extent of non-random
clustering of HLA-DR1 on the surface of the B cells imaged would
result in the following trends in the FRET % vs. [Acceptor] plots:
(i) a lack of dependence of FRET % on [Acceptor] irrespective of
the D:A ratio, and (ii) an increase in FRET % with an increase in
molar fraction of the donor. For clarity, only the group with D:A
ratio of 1:4 is shown; the data with D:A ratios of 1:1, 1:2 and 1:4
are included in Supplementary Fig. S3.
On inspection of the FRET % vs. [Acceptor] graphs for the
various groups, some trends are clearly visible. In the absence of
SEA treatment (Fig. 2C, i) there is an obvious dependence of
FRET % on [Acceptor]. The addition of the control SAg SEH
does not increase clustering of surface DR1 on B cells in the
presence or absence of EDTA (Fig. 2C, ii, iii). However, the
addition of 10 mg or 2.5 mg SEA per 10
6 B cells per mL decreases
the dependence of FRET % vs. Acceptor density, resulting in
lower curvilinearity and a smaller slope in the best fit line that
defines the FRET % for a given D:A ratio (Fig. 2C, iv, vi). The
efficiency of energy transfer is especially high at the higher dose of
SEA, indicating substantial clustering of surface DR1 at this dose
of SAg. This increase in clustering is reversed by the inactivation of
the Zn
2+ dependent binding site with EDTA (Fig. 2C, v).
Inspection of the plots of FRET% vs. various D:A ratios also
support these conclusions. Treatment with SEA causes an
increased correlation between FRET % and D:A ratio, resulting
in greater separation between FRET % values, or a greater
difference between the intercepts for the fits, for the various ratios.
This is reversed by either the addition of EDTA or treatment with
SEH (Supplementary Fig. S3A, B), suggesting that SEA but
not SEH mediates the formation of clusters of DR1 molecules on
B cells via both its binding sites.
SEA does not induce large-scale aggregation of
immunogold labeled DR1
We employed electron tomography and electron microscopy of
thick and thin sections respectively, of immunolabeled, fixed,
plastic-embedded cells to independently test the conclusions from
the FRET experiments, and in addition, gain insights into the size
of the clusters induced by SEA. We isolated B cells and treated
them with various superantigens in the presence or absence of
EDTA as before. We then used excess unlabeled anti-DR1
antibody L243 to bind surface HLA-DR1 on these B cells,
followed by fixing and then staining with 6 nm gold bead
conjugated secondary antibodies to prevent antibody mediated
clustering. To assess the three dimensional surface distribution of
DR1 on the surface of B cells, we performed electron tomography
on 250 nm thick sections obtained from labeled cells (see Materials
and Methods). Electron tomography allows visualization of sub-
cellular assemblies in 3D at resolutions higher than light
microscopy [25] and is ideally suited to determine the spatial
distribution of the 6 nm gold markers at the B cell membrane
(Supplementary Movie S1). The tomograms generated were
segmented to highlight the locations of the gold particles on the
surface of treated or untreated cells (Fig. 3, Supplementary
Movie S2). There was no obvious indication of large-scale
aggregation or capping of surface DR1 induced by SEA. Indeed,
there were no striking differences in clustering between the various
control groups (Fig. 3A–D). It is noteworthy that even in the
stretches of membrane with a high density of gold-labeled DR1
(Fig. 3E, F), the addition of SEA did not produce an obvious
change in the degree of clustering. In sharp contrast, the addition
of primary antibody followed by gold-labeled polyclonal secondary
at 37uC caused the formation of large aggregates or capping of
MHC class II on the B cell surface (Fig. 3G). The capping is not
because of unnaturally high surface expression of DR1 because
there are areas that have baseline levels of DR1 (arrowheads)
immediately adjacent to the areas that have large aggregates of
DR1 (arrows with asterisks). This forced capping also caused an
increased incidence of membrane ruffling of the cell and
internalization of DR1 (Supplementary Fig. S4A, B), which
was not observed with the SEA treated cells.
While there were no dramatic changes in the clustering of gold-
labeled DR1 among the various groups of B cells, there were
subtle differences in the distribution of gold beads that suggested
that inspection of a greater number of cells may give rise to
statistically significant differences in clustering between the
experimental groups. Since this could be achieved at higher
throughput with 2D imaging, we obtained projection electron
microscopic images of thin sections (,80 nm) of the B cells treated
as above (Fig. 4A i, ii). In a ‘‘blinded’’ experiment, many such
slices (.30/group) were examined, and the distances between
adjacent gold beads were measured along the contour of the cell
membrane. With both the tomographic (3D) and projection (2D)
imaging experiments, the addition of SEA or SEH did not appear
to have altered the gross morphology or the overall extent of
staining of DR1 molecules on the cell membrane (Fig. 4A).
A ‘‘nearest neighbor’’ analysis of 200 measurements from each
group showed that untreated and SEH treated B cells showed a
similar distribution of gold beads with comparable distances
between adjacent gold beads (Fig. 4B yellow, blue). However,
SEA treated cells (red) showed a marked increase of ,1.8 fold in
the proportion of closely apposed gold beads as compared to
untreated or SEH-treated cells. The addition of SEA/EDTA
(green) showed an intermediate distribution. The differences in
gold bead distribution between the various groups were greatest
when the distance between nearest neighbors was 60–80 nm, and
these differences diminished at greater inter-bead distances.
Taking into consideration these data and the approximate
molecular sizes of DR1 and SEA, we chose 75 nm as our
‘‘clustering cut-off’’, i.e., the farthest distance possible between two
adjacent gold beads that labeled DR1 molecules actively clustered
Table 1. Presence of SEA or SEH does not significantly alter
the affinity of the anti HLA-DR1 probe L243.
Kd(nM) Bmax
untreated 7.9060.41 295.6063.69
SEH 10.7960.60 286.9564.01
SEA 9.7060.77 260.2565.15
B cells from DR1tg mice incubated with no enterotoxin or 2.5 mg SEA or SEH for
1 hour at 37uC were stained with various dilutions of Cy3-L243 and analyzed by
flow cytometry. Plots of L243 concentration vs. Mean Fluorescence Index were
then fitted to a two-step binding equation (see data analysis) to obtain Kd,
Bmax values. Standard deviations are in parentheses.
doi:10.1371/journal.pone.0006188.t001
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75 nm apart are counted as ‘‘clustered’’.
Untreated B cells showed a wide spread in % beads clustered
(Fig. 4C, yellow). On examination of over 200 cell sections
individually, we saw that SEA caused a significant increase in non-
random distribution or clustering of HLA-DR1 on the surface of B
cells in the presence of Zn
2+ with a mean of 58% beads clustered
(Fig. 4C, red). The addition of EDTA to disrupt the zinc-
dependent high affinity binding site significantly lowered the
proportion of clustered beads, as expected (mean ,46%), while
the addition of the control SAg SEH caused a small, but
insignificant decrease in DR1 clustering on the B cells (Fig. 4C,
green, blue). Finally, we found that the number of higher order
clusters on the B cells (clusters with more than two gold beads) was
not dramatically altered by the addition of SEA (Fig. 4D). There
was only a small shift towards higher order clusters; most of the
clusters imaged were labeled by 2–4 gold beads, and this was
partially reversed by EDTA. We thus conclude that SEA, even in
the absence of anti-DR1 antibodies or T Cells, can crosslink DR1
molecules to form small clusters on the surface of B cells.
Discussion
SEA is an unusual bacterial superantigen in that it has two
binding sites for two corresponding sites on the MHC class II
molecule. Here, using specific probes in conjunction with powerful
imaging techniques of FRET, electron microscopy and tomogra-
phy, we visualize the generation of small clusters of DR1 molecules
on the surface of primary B lymphocytes upon SEA treatment. It is
important to clarify here that in using the term ‘‘clustering’’, we do
not imply the covalent cross-linking of various proteins described
in this study. Rather, we wish to convey the accretion of SEA and
DR1 molecules on the B cell membrane, mediated by moderate to
high affinity non-covalent interactions between these two proteins.
The term ‘‘clustering’’ has indeed been increasingly utilized to
mean as such by Immunologists who study the spatial re-
organization of various cell-surface receptors [36,37]. Our FRET
studies showed a high degree of clustering of DR1 molecules
induced by SEA; this was dependent on the dose of SEA and the
presence of both binding sites. We also observed that FRET
efficiency dropped off dramatically at lower concentrations of SEA
(data not shown). This sharp increase in MHC class II clustering
with increasing SEA concentration was predicted by a cooperative
model of SEA-DR binding [13,38]. Initially, with our electron
microscopic studies, there appeared to be only subtle differences in
the clustering between the SEA-treated B cells and controls. On
the inspection of large areas of the B cell membrane in three
dimensions and at nanometer resolution by electron tomography,
we observed no large aggregates of gold-labeled DR1 in the SEA
treated cells. On the other hand, forced clustering of DR1 by
polyclonal antibodies resulted in large aggregates or ‘‘capping’’ of
DR1, along with internalization of DR1 into intracellular vesicles
and extensive ruffling of the B cell membrane; neither of these
were observed with SEA treatment. However, when we inspected
large numbers of B cells, there emerged significant differences
between the groups. Treatment of B cells with SEA but not SEH
resulted in an increase in DR1 clusters, most of which were labeled
by no more than 4 gold particles, and this increase in clustering
was partially reversed by the inactivation of one of the two SEA
binding sites by EDTA.
How can we reconcile the FRET data that suggested strong
clustering, with the results from the electron microscopic imaging?
We argue that these data are in fact internally consistent; the
FRET assay as performed is not sensitive to the size of the DR1
cluster. While we can show that DR1 molecules on the B cell
surface are clustered, we cannot establish whether these molecules
form a few large clusters, i.e. aggregates of DR1, or many small
independent clusters. The electron microscopic imaging experi-
ments suggest that the latter is the case, and strongly argue against
extensive aggregation of surface DR1. The precise size of these
small clusters cannot be resolved at present because the
immunogold experiments only result in the labeling of a small
fraction of the total antigen population. A recent study of CD19
clustering on B cells suggested microclusters of anywhere between
100–500 molecules of B Cell Receptors upon activation [39].
However, modeling studies of SEA-DR2 trimers [40] reveal an
almost orthogonal ‘‘kink’’ in the trimer, such that one can imagine
that the extent of cross-linking of DR1 by SEA on a cell
membrane could potentially be self-limiting to no more than 4–5
DR1 molecules due to steric constraints. Thus, we conclude that
our results can be explained by a model where SEA clusters DR1
to form many small microclusters or ‘‘daisy-chain’’ oligomers [38],
but do not result in the coalescence or aggregation of MHC class
II molecules on the surface of B cells [12,21].
How do these observations translate into explaining the
functionality of SEA? Firstly, clustering of membrane proteins is
an oft-repeated theme in biological signaling, A central event in T
cell activation for example, is the formation of the immune synapse
(IS), where sustained cell signaling results from an orchestrated set
of clustering events of various receptors on both the T cell and
Antigen Presenting Cell membranes [43]. It is certainly likely that
a similar set of clustering events, in this case on the DR1
expressing B cell membrane, could be initiated by SEA binding
and crosslinking DR1 molecules. The intracellular signaling
observed in DR1 expressing cells only when they were treated
with SEA that had both functional binding sites [19] was
construed to mean that SEA could crosslink DR1 molecules,
and that this was necessary to initiate cell signaling. Our results are
compatible with these hypotheses, and go one step further to show
that the SEA-mediated crosslinking results in the formation of
small clusters of DR1 on the cell surface. While we required excess
SEA to visualize a statistically significant number of instances of
these clusters, it must be noted that SEA exerts its toxic effects at
far lower concentrations [2,5,6]. Thus it is possible that the
induction of only a few small-scale clusters per cell by SEA could
suffice to initiate downstream intracellular signaling. Given that
DR1 molecules are also retained at the cell surface and not
endocytosed for long periods of time when bound by functional
Figure 2. SEA induces clustering of HLA-DR1 on the B cell surface. (A) Acceptor Photobleach experiments can quantitatively measure energy
transfer. Images of B cells isolated from wtDR1 transgenic mice were stained with Donor (Cy3) and Acceptor (Cy5) conjugated anti-DR monoclonal
antibodies (L243) at Donor:Acceptor ratios of (1:1) before (i, ii) and after (iii, iv) acceptor photobleaching, indicated by arrow. Donor channel, i, iii;
acceptor channel, ii, iv. The photobleached area is boxed in the range indicator (to the right of each image). (B) FRET in the various regions of interest
(ROI) on the cell surface (overlay, i) can be quantified from changes in the intensity in the Donor and Acceptor channels (ii). Acceptor photobleach
(red) results in variable increase in Donor intensity (green; ROI 1, iii; ROI 1a, iv), while control ROIs 2 and 3 (v,vi) show little change in donor and
acceptor intensities. (C) SEA induces clustering of HLA-DR1 on B cells. Energy Transfer (E%) values were plotted against acceptor Fluorescence ([A] pre-
bleach) for untreated B cells (i), B cells treated with with SEH +/2 EDTA (ii,iii), SEA in the presence of EDTA (iv) or B cells treated with 10 mg or 2.5 mg
SEA (v,vi) for 45 minutes, here, at Donor:Acceptor molar ratio 1:4. Data from one of two experiments.
doi:10.1371/journal.pone.0006188.g002
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primary and gold-labeled secondary antibodies, fixed and analyzed. Representative tomograms of 250 nm thick sections of these cells were
generated and segmented to highlight the 3D distribution of DR1 labeled by 6 nm gold beads (gold spheres) on the B cell membrane (purple). B cells
were untreated (A), treated with SEA+Zn
2+ (B), SEA+EDTA (C) or SEH (D). Representative stretches of cell membrane with a higher density of DR1 in
cells treated with SEA (E), or untreated B cells (F) also showed no aggregates. Forced crosslinking of DR1 (G) caused aggregation (capping) of DR1 in
some areas (black arrow/asterisk) but not others (white arrowhead).
doi:10.1371/journal.pone.0006188.g003
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exist as stable clusters over time, could also serve to sustain cell
signaling. This would explain the downstream signaling seen in
cells exposed to very low doses of SEA. Thus, it is certainly
tempting to view a single small cluster of 4–5 MHC class II
molecules as the smallest ‘‘signaling unit’’ of an Antigen Presenting
Cell, although the direct observation of these rare small clusters
over time is impossible with current technologies.
In the case of T cells, these cells require only a small number of
ligands (here, potentially both SEA and DR1) to trigger T Cell
Receptors (TCR) clustering and downstream activation [41,42]. In
this study, we deliberately excluded T cells so as to exclusively
study the effect of SEA on B cells expressing DR1 alone. However,
we posit that the small-scale clustering of DR1 molecules by SEA
that we observed on the surface of Antigen Presenting Cells may
serve to increase the local concentration of TCR ligands and thus
Figure 4. SEA induces small clusters of HLA-DR1 on the B cell surface. B cells were treated, stained and fixed as in Figure 3, and thin sections
(80 nm) analyzed by transmission electron microscopy. (A) Images of untreated B cells (i) or B cells treated with 2.5 mg SEA (ii) showed varying
degrees of clustering of HLA-DR1. arrow/asterisk, ‘‘clustered’’ gold beads; arrowhead, ‘‘unclustered’’ gold beads. (B) Nearest neighbor analysis of B
cells treated with SEA (red) shows an increased number of closely apposed gold beads compared to B cells treated with no enterotoxin (yellow)o r
SEH (blue). SEA+EDTA (green) has an intermediate distribution, and these differences disappear when nearest neighbors are separated by large
distances. m, separation at 75 nm. (C) B cells treated with SEA show a statistically significant increase in the fraction of beads that are within 75 nm of
each other, when compared to cells that were untreated or treated with SEH or SEA+EDTA. Same color scheme as above. (D) SEA treatment does not
mediate higher order aggregation of HLA-DR1. Equivalent stretches of B cell membranes of various groups were evaluated for number of instances of
‘‘higher order’’ clusters (clusters of .2 gold beads). There was an increase in the fraction of cells with higher order clusters on SEA treatment, but no
dramatic change in the distribution profile between the groups. Data pooled from two experiments.
doi:10.1371/journal.pone.0006188.g004
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MHC II molecules to facilitate antigen presentation is not an
entirely new concept in Immunology, and indeed has been
previously studied in conjunction with lipid rafts [43,44]. While we
have not studied the re-organization of lipids in this study, we
subscribe to the possibility that small clusters of TCR-SEA-DR1
may be sufficient to recruit and perhaps cluster signaling
molecules, and initiate signaling downstream of TCRs. It is
noteworthy that the addition of such a potent T cell activator only
results in the formation of small clusters of MHC class II molecules
on B cell surfaces. The implicit suggestion from our studies that
small-scale membrane receptor clustering might be sufficient to
initiate downstream makes it interesting to speculate that in the
absence of superantigens, such clustering, possibly even without
the formation of large-scale ordered ‘‘immune synapses’’, could
initiate T cell signaling and perhaps explain the sensitivity and
non-linearity of the T cell response to low concentrations of
antigen. Certainly, in the case of SEA, the clustering of MHC class
II molecules on antigen presenting cells by this superantigen may
be the underlying mechanism behind the extremely low
concentration of SEA required to trigger the hyperactive, and
sometimes lethal, immune response.
Supporting Information
Figure S1 SEA treatment does not cause capping of surface
DR1 on B cells. (A) Freshly isolated B cells treated with SEA for
various lengths of time and stained for DR1 using L243-FITC
showed fairly even receptor distribution around the cell. (B) Cells
stained with anti-DR1-FITC and polyclonal secondary antibodies
at 37oC showed typical receptor aggregation or ‘‘capping’’.
Found at: doi:10.1371/journal.pone.0006188.s001 (0.56 MB PPT)
Figure S2 SEA treatment does not cause significant internali-
zation of surface DR1 on B cells (A) Cells isolated from the spleens
of DR1 transgenic mice and negatively selected on a CD43
column were 90–95% B220+ B lymphocytes. (B) These cells
incubated for various time points with 2.5 mg/mL/106 B cells
SEA, and stained for surface DR1 with L243-FITC.
Found at: doi:10.1371/journal.pone.0006188.s002 (0.10 MB PPT)
Figure S3 SEA but not SEH increases clustering of surface DR1
on B cells. (A) Shown is the data from all the D:A ratios used for
Figure 2c. The addition of SEA causes an increase in dependence
of FRET (E%) values to the D:A ratio, resulting in a greater
separation between the groups, which is visually apparent. This
separation is markedly reduced in the control groups. (B) The
intercepts of the linear fits applied to these data showed a dose
dependent increase in E% for SEA treated cells as would be
predicted, but not in the control groups. Again, EDTA reduces the
SEA induced clustering of DR1.
Found at: doi:10.1371/journal.pone.0006188.s003 (0.33 MB
DOC)
Movie S1 Acquisition of Tilt series. A thick section of embedded
and stained B cell (see Materials and Methods) was imaged at tilt
angles ranging from 260u to +60u at 2u increments, cross-
correlated and the individual images sequentially output as a
movie. The gold fiducials appear as large dark dots, while the
5 nm gold markers which label the surface MHC class II appear as
small dots on the cell membrane (the nucleus is on the bottom
right). The latter are easier to visualize when the movie is allowed
to play at normal speed, and appear most prominently at lower tilt
angles, e.g. a group of gold beads near the centre of the image, to
the top-left of the small spherical vesicle.
Found at: doi:10.1371/journal.pone.0006188.s004 (3.85 MB
MPG)
Movie S2 Tomogram. A dataset comprising of images of the
thick section of the gold bead decorated B cell taken at different tilt
angles was used to generate a tomogram. The same dataset used to
make movie S1 was used to generate the volume shown in S2. As
one ‘‘walks through’’ the 3D volume, the gold beads appear
transiently at high contrast at appropriate z slices. The fiducials
appear as the larger black dots towards the start and end of the
volume, while the 5 nm gold particles appear throughout the
volume and are restricted to the membrane, where they
presumably have bound MHC class II molecules
Found at: doi:10.1371/journal.pone.0006188.s005 (7.26 MB
MPG)
Movie S3 Image segmentation. The tomogram generated above
was segmented by Amira to highlight a section of the B cell
membrane (purple) and the 3D distribution of some of the gold
bead labeled DR1 molecules. Gold spheres with a diameter of
,15 nm were placed at the xyz coordinates corresponding to
location of the gold beads in the tomogram. For clarity, the other
aspects of the tomogram such as the nuclear membrane etc were
left unhighlighted. Still images from segmented 3D volumes such
as these are represented in Figure 3 in the main manuscript.
Found at: doi:10.1371/journal.pone.0006188.s006 (5.81 MB
MPG)
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